Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives $13.31 Consensus Target Price from Analysts
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have received a consensus rating of “Hold” from the twelve research firms that are covering the firm, Marketbeat reports. Twelve investment analysts have rated the stock with a hold recommendation. The average 1 year price target among brokers that have covered the stock in the […]
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have received a consensus rating of “Hold” from the twelve research firms that are covering the firm, Marketbeat reports. Twelve investment analysts have rated the stock with a hold recommendation. The average 1 year price target among brokers that have covered the stock in the […]
